神州细胞（688520）披露2025年度向特定对象发行股票获证监会同意注册批复，1月5日股价上涨8.29%

Core Viewpoint - Shenzhou Cell (688520) has received approval from the China Securities Regulatory Commission (CSRC) for a specific stock issuance, which is expected to enhance its capital structure and support future growth initiatives [1][2] Group 1: Stock Performance - As of January 5, 2026, Shenzhou Cell's stock closed at 46.9 yuan, marking an increase of 8.29% from the previous trading day [1] - The stock opened at 43.25 yuan, reached a high of 47.25 yuan, and a low of 43.18 yuan during the trading session [1] - The total market capitalization of the company is reported at 20.886 billion yuan, with a trading volume of 2.88 billion yuan and a turnover rate of 1.41% [1] Group 2: Regulatory Approval - The company has received a formal approval from the CSRC for its application to issue stocks to specific investors, as indicated in the official document (Approval No. 2971) [1] - The approval is valid for 12 months from the date of issuance, allowing the company to proceed with the necessary issuance procedures within the stipulated timeframe [1]